BRASKEM SA (BAK) [Rocket]

Overview

BRASKEM SA (BAK)

Add to portfolio

Recent News + Filings (All items)

Date Filed	Type	Description
10/11/2023	6-K	Quarterly results
10/10/2023	6-K	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
10/10/2023	6-K	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
09/26/2023	6-K	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
08/23/2023	6-K	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
08/16/2023	6-K	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
08/15/2023	6-K	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

Revenue Mix by Segment

Financial Summary (All financials)

In millions, except per share items	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16	Dec-31-15	Dec-31-14
Revenues	0.0	0.0	0.0	0.0	0.0	0.0	-26,914.4	-33,905.0
Revenue growth						-100.0%	-20.6%	10.6%
Cost of goods sold	0.0	0.0	0.0	0.0	0.0	0.0	-37,238.4	-39,831.0
Gross profit	0.0	0.0	0.0	0.0	0.0	0.0	10,324.0	5,926.0
Gross margin							-38.4%	-17.5%
Selling, general and administrative	0.0	0.0	0.0	0.0	0.0	0.0
Sales and marketing	0.0	0.0	0.0	0.0	0.0	0.0	1,122.0	1,083.5
Research and development							169.6	128.1
General and administrative	0.0	0.0	0.0	0.0	0.0	0.0	1,339.8	1,254.7
EBIT	0.0	0.0	0.0	0.0	0.0	0.0	6,938.5	3,477.6
EBIT margin							-25.8%	-10.3%
Pre-tax income	17,961.0	-9,683.8	-4,603.1	0.0	0.0	0.0	0.0	0.0
Income taxes	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Tax rate	0.0%	0.0%	0.0%
Net income	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Net margin							0.0%	0.0%

Diluted EPS							$0.00	$0.00
Shares outstanding (diluted)							3.8	0.9

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.